Hildebrandt M - Search Results

1

Nongenotoxic activation of the p53 pathway as a therapeutic strategy for multiple myeloma.

Stühmer T, Chatterjee M, Hildebrandt M, Herrmann P, Gollasch H, Gerecke C, Theurich S, Cigliano L, Manz RA, Daniel PT, Bommert K, Vassilev LT, Bargou RC. Stühmer T, et al. Among authors: hildebrandt m. Blood. 2005 Nov 15;106(10):3609-17. doi: 10.1182/blood-2005-04-1489. Epub 2005 Aug 4. Blood. 2005. PMID: 16081689 Free article.

2

Monitoring of tumor cell purging after highly efficient immunomagnetic selection of CD34 cells from leukapheresis products in breast cancer patients: comparison of immunocytochemical tumor cell staining and reverse transcriptase-polymerase chain reaction.

Mapara MY, Körner IJ, Hildebrandt M, Bargou R, Krahl D, Reichardt P, Dörken B. Mapara MY, et al. Among authors: hildebrandt m. Blood. 1997 Jan 1;89(1):337-44. Blood. 1997. PMID: 8978310 Free article.

3

Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency.

Hildebrandt M, Mapara MY, Körner IJ, Bargou RC, Moldenhauer G, Dörken B. Hildebrandt M, et al. Exp Hematol. 1997 Jan;25(1):57-65. Exp Hematol. 1997. PMID: 8989908

4

Hildebrandt M, Dijkstra D, Gollasch H, Daemen K, Stevanovic-Meyer M, Ludwig WD. Hildebrandt M, et al. Transfusion. 2012 Apr;52(4):765-76. doi: 10.1111/j.1537-2995.2011.03351.x. Epub 2011 Sep 26. Transfusion. 2012. PMID: 21950525

5

Detection of tumor cells in peripheral blood samples from patients with germ cell tumors using immunocytochemical and reverse transcriptase-polymerase chain reaction techniques.

Hildebrandt MO, Bläser F, Beyer J, Siegert W, Mapara MY, Huhn D, Salama A. Hildebrandt MO, et al. Bone Marrow Transplant. 1998 Oct;22(8):771-5. doi: 10.1038/sj.bmt.1701416. Bone Marrow Transplant. 1998. PMID: 9827974

6

Immunomagnetic selection of CD34+ cells: factors influencing component purity and yield.

Hildebrandt M, Serke S, Meyer O, Ebell W, Salama A. Hildebrandt M, et al. Transfusion. 2000 May;40(5):507-12. doi: 10.1046/j.1537-2995.2000.40050507.x. Transfusion. 2000. PMID: 10827251

7

Detection of germ-cell tumor cells in peripheral blood progenitor cell harvests: impact on clinical outcome.

Hildebrandt M, Rick O, Salama A, Siegert W, Huhn D, Beyer J. Hildebrandt M, et al. Clin Cancer Res. 2000 Dec;6(12):4641-6. Clin Cancer Res. 2000. PMID: 11156214

8

PBPC mobilization with paclitaxel, ifosfamide, and G-CSF with or without amifostine: results of a prospective randomized trial.

Rick O, Schwella N, Beyer J, Dubiel M, Krusch A, Hildebrandt M, Schleicher J, Serke S, Siegert W. Rick O, et al. Among authors: hildebrandt m. Transfusion. 2001 Feb;41(2):196-200. doi: 10.1046/j.1537-2995.2001.41020196.x. Transfusion. 2001. PMID: 11239222 Clinical Trial.

9

Analysis of CD34-expressing cells in clinical practice.

Serke S, Beyer J, Rick O, Schwella N, Meyer O, Hildebrandt M, Huhn D. Serke S, et al. Among authors: hildebrandt m. Vox Sang. 1998;74 Suppl 2:469-75. doi: 10.1111/j.1423-0410.1998.tb05459.x. Vox Sang. 1998. PMID: 9704484 Review.

10

Human miscarriage is associated with increased number of CD26 decidual lymphocytes.

Sehmsdorf US, Zenclussen AC, Arck P, Hertwig K, Joachim RA, Klapp B, Hildebrandt MO. Sehmsdorf US, et al. Among authors: hildebrandt mo. Scand J Immunol. 2004 Apr;59(4):400-7. doi: 10.1111/j.0300-9475.2004.01406.x. Scand J Immunol. 2004. PMID: 15049784 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

396 results

Search Page